Cargando…

Neoadjuvant Chemotherapy prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer: A Systematic Review

High-risk prostate cancer represents a pretentious clinical problem since a significant number of its patients will relapse and progress after radical prostatectomy. Neoadjuvant chemotherapy may be valuable since its efficacy in hormone-resistant prostate cancer has been established. In this paper,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sfoungaristos, Stavros, Kourmpetis, Vasileios, Fokaefs, Eleftherios, Perimenis, Petros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594907/ https://www.ncbi.nlm.nih.gov/pubmed/23509625 http://dx.doi.org/10.1155/2013/386809

Ejemplares similares

Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 Months
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Early Continence Recovery after Preservation of Maximal Urethral Length until the Level of Verumontanum during Radical Prostatectomy: Primary Oncological and Functional Outcomes after 1 Year of Follow-Up
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
por: Abdul Sater, Houssein, et al.
Publicado: (2020)

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
por: Wei, Yongbao, et al.
Publicado: (2023)

Neoadjuvant chemotherapy before radical prostatectomy for locally advanced prostate cancer: Protocol for a systematic review and meta-analysis
por: Lin, Tianhai, et al.
Publicado: (2019)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer
por: Zhang, Peng, et al.
Publicado: (2022)

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Ge, Qingyu, et al.
Publicado: (2022)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

The role of radical prostatectomy in high-risk prostate cancer
por: Chung, Byung Ha
Publicado: (2013)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

Prostate MRI prior to radical prostatectomy: effects on nerve sparing and pathological margin status
por: Druskin, Sasha C, et al.
Publicado: (2017)

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
por: Joung, Jae Young, et al.
Publicado: (2015)

Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
por: Kumon, Hiromi, et al.
Publicado: (2015)

Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer
por: Hou, Cheng-Pang, et al.
Publicado: (2014)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Platinum-Based Neoadjuvant Chemotherapy Before Radical Prostatectomy for Locally Advanced Prostate Cancer With Homologous Recombination Deficiency: A Case Report
por: Zhuang, Junlong, et al.
Publicado: (2022)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Retzius-sparing robot-assisted radical prostatectomy is safe for patients with prior transurethral prostate surgery
por: Kim, Lawrence H. C., et al.
Publicado: (2018)

Neoadjuvant Androgen Deprivation Therapy Effects on Perioperative Outcomes Prior to Radical Prostatectomy: Eleven Years of Experiences at Ramathibodi Hospital
por: Sangkum, Premsant, et al.
Publicado: (2021)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
por: Marchioro, Giansilvio, et al.
Publicado: (2012)

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives
por: Canda, Abdullah Erdem, et al.
Publicado: (2015)

Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
por: Nagao, Kazuhiro, et al.
Publicado: (2018)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma
por: Brunner, Robert, et al.
Publicado: (2019)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

Letter to the editor: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions
por: Spartalis, Eleftherios, et al.
Publicado: (2018)

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
por: Kumon, H, et al.
Publicado: (2016)

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
por: Lee, Lui Shiong, et al.
Publicado: (2022)

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
por: Naiki, Taku, et al.
Publicado: (2012)

Deep sedation in GreenLight laser prostatectomy
por: Fligou, Fotini, et al.
Publicado: (2016)

Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer
por: Sood, Akshay, et al.
Publicado: (2014)

Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
por: Chun, Seok-Joo, et al.
Publicado: (2021)

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
por: Lee, Lui Shiong, et al.
Publicado: (2022)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
por: Oishi, Takuya, et al.
Publicado: (2023)

The Impact of Neoadjuvant Hormone Therapy on Surgical and Oncological Outcomes for Patients With Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Zhang, Lijin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7bkt7p4u0jl16l7405nts89s8a